Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BROKEN-SWEDEHEART- Optimized Pharmacological Treatment for Broken Heart (Takotsubo) Syndrome. A Multinational, Multicentre, Registry-based, Open-label, Randomized Controlled Trial.

NCT04666454 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.

NCT NCT04666454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04666454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BROKEN-SWEDEHEART- Optimized Pharmacological Treatment for Broken Heart (Takotsubo) Syndrome. A Multinational, Multicentre, Registry-based, Open-label, Randomized Controlled Trial.
Lead sponsor
Vastra Gotaland Region
Phase
Phase 4
Overall status
Recruiting
Start date
December 14, 2020
Completion date
December 31, 2028
Enrollment
1,000 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

takotsubo syndrome